Evidence map›Paper›PMID 37092613›Full record

ArticleActa bio-medica : Atenei Parmensis2023

Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: Response.

Olga Izmailova, Oksana Shlykova, Alina Kabaliei, Anastasia Vatsenko, Dmytro Ivashchenko, Maksym Dudchenko, Andrii Volianskyi, Gennadiy Zelinskyy, Tetiana Koval, Ulf Dittmer and 1 more

Abstract readLetterComment
In one paragraph

Article in Acta bio-medica : Atenei Parmensis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Olga IzmailovaScientific Research Institute of Genetic and Immunological Grounds of Pathology and Pharmacogenetic, Poltava State Medical University, Poltava, Ukraine. o.izmailova@pdmu.edu.ua.
Oksana ShlykovaScientific Research Institute of Genetic and Immunological Grounds of Pathology and Pharmacogenetic, Poltava State Medical University, Poltava, Ukraine. o.shlykova@pdmu.edu.ua.
Alina KabalieiScientific Research Institute of Genetic and Immunological Grounds of Pathology and Pharmacogenetic, Poltava State Medical University, Poltava, Ukraine. virens@ukr.net.
Anastasia VatsenkoDepartment of infectious diseases with epidemiology, Poltava State Medical University, Poltava, Ukraine. vatsenko.anastasia@gmail.com.
Dmytro IvashchenkoDepartment of surgery No. 4 with minimally invasive surgery, Poltava State Medical University, Poltava, Ukraine. dimitrol.i@gmail.com.
Maksym DudchenkoDepartment of surgery No. 4 with minimally invasive surgery, Poltava State Medical University, Poltava, Ukraine. dudchenkomax@gmail.com.
Andrii VolianskyiLaboratory of Immunorehabilitology, Mechnikov Institute of Microbiology and Immunology, Kharkiv, Ukraine. improf@ukr.net.
Gennadiy ZelinskyyInstitute for Virology, University Medicine Essen, University Duisburg-Essen, Germany. gennadiy.zelinskyy@uk-essen.de.
Tetiana KovalDepartment of infectious diseases with epidemiology, Poltava State Medical University, Poltava, Ukraine. kovalti@ukr.net.
Ulf DittmerInstitute for Virology, University Medicine Essen, University Duisburg-Essen, Germany. ulf.dittmer@uk-essen.de.
Igor KaidashevDepartment of Internal Medicine No3 with Phthisiology, Poltava State Medical University, Poltava, Ukraine. i.kaidashev@pdmu.edu.ua.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

.

Indexed as

COVID-19HumansPolymorphism, GeneticSerine EndopeptidasesSerine EndopeptidasesTMPRSS2 protein, human

Identifiers

PMID37092613
PMCPMC10210578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.